Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

Anesthesia Practice in Pediatric Radiation Oncology: Mayo Clinic Arizona's Experience 2014-2016.

Khurmi N, Patel P, Koushik S, Daniels T, Kraus M.

Paediatr Drugs. 2017 Aug 7. doi: 10.1007/s40272-017-0259-8. [Epub ahead of print]

PMID:
28786083
2.

Pharmacologic Considerations for Pediatric Sedation and Anesthesia Outside the Operating Room: A Review for Anesthesia and Non-Anesthesia Providers.

Khurmi N, Patel P, Kraus M, Trentman T.

Paediatr Drugs. 2017 Jun 8. doi: 10.1007/s40272-017-0241-5. [Epub ahead of print] Review.

PMID:
28597354
3.

Perioperative considerations for patients with sickle cell disease: a narrative review.

Khurmi N, Gorlin A, Misra L.

Can J Anaesth. 2017 Aug;64(8):860-869. doi: 10.1007/s12630-017-0883-3. Epub 2017 Apr 28.

PMID:
28455727
4.

Patterns of Care and Outcomes in Cardiovascular Disease After Kidney Transplantation in the United States.

Mathur AK, Chang YH, Steidley DE, Heilman R, Khurmi N, Wasif N, Etzioni D, Moss AA.

Transplant Direct. 2017 Jan 16;3(2):e126. doi: 10.1097/TXD.0000000000000640. eCollection 2017 Feb.

5.

Angioedema: Classification, management and emerging therapies for the perioperative physician.

Misra L, Khurmi N, Trentman TL.

Indian J Anaesth. 2016 Aug;60(8):534-41. doi: 10.4103/0019-5049.187776. Review.

6.

Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial.

Holman RR, Bethel MA, George J, Sourij H, Doran Z, Keenan J, Khurmi NS, Mentz RJ, Oulhaj A, Buse JB, Chan JC, Iqbal N, Kundu S, Maggioni AP, Marso SP, Öhman P, Pencina MJ, Poulter N, Porter LE, Ramachandran A, Zinman B, Hernandez AF.

Am Heart J. 2016 Apr;174:103-10. doi: 10.1016/j.ahj.2015.12.009. Epub 2015 Dec 21.

PMID:
26995376
7.

Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial.

Mahaffey KW, Held C, Wojdyla DM, James SK, Katus HA, Husted S, Steg PG, Cannon CP, Becker RC, Storey RF, Khurmi NS, Nicolau JC, Yu CM, Ardissino D, Budaj A, Morais J, Montgomery D, Himmelmann A, Harrington RA, Wallentin L; PLATO Investigators.

J Am Coll Cardiol. 2014 Apr 22;63(15):1493-9. doi: 10.1016/j.jacc.2014.01.038. Epub 2014 Feb 19.

8.

Ticagrelor versus clopidogrel in patients with acute coronary syndromes and a history of stroke or transient ischemic attack.

James SK, Storey RF, Khurmi NS, Husted S, Keltai M, Mahaffey KW, Maya J, Morais J, Lopes RD, Nicolau JC, Pais P, Raev D, Lopez-Sendon JL, Stevens SR, Becker RC; PLATO Study Group.

Circulation. 2012 Jun 12;125(23):2914-21. doi: 10.1161/CIRCULATIONAHA.111.082727. Epub 2012 May 9.

9.

Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function substudy).

Storey RF, Becker RC, Harrington RA, Husted S, James SK, Cools F, Steg PG, Khurmi NS, Emanuelsson H, Lim ST, Cannon CP, Katus HA, Wallentin L.

Am J Cardiol. 2011 Dec 1;108(11):1542-6. doi: 10.1016/j.amjcard.2011.07.015. Epub 2011 Sep 3.

PMID:
21890085
10.

Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes.

Storey RF, Becker RC, Harrington RA, Husted S, James SK, Cools F, Steg PG, Khurmi NS, Emanuelsson H, Cooper A, Cairns R, Cannon CP, Wallentin L.

Eur Heart J. 2011 Dec;32(23):2945-53. doi: 10.1093/eurheartj/ehr231. Epub 2011 Jul 30.

PMID:
21804104
11.

Efficacy and safety of rosuvastatin 5 mg in combination with fenofibric acid 135 mg in patients with mixed dyslipidemia - a phase 3 study.

Roth EM, Rosenson RS, Carlson DM, Fukumoto SM, Setze CM, Blasetto JW, Khurmi NS, Stolzenbach JC, Williams LA.

Cardiovasc Drugs Ther. 2010 Dec;24(5-6):421-8. doi: 10.1007/s10557-010-6266-4.

PMID:
20953684
12.

Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study.

Cannon CP, Harrington RA, James S, Ardissino D, Becker RC, Emanuelsson H, Husted S, Katus H, Keltai M, Khurmi NS, Kontny F, Lewis BS, Steg PG, Storey RF, Wojdyla D, Wallentin L; PLATelet inhibition and patient Outcomes Investigators.

Lancet. 2010 Jan 23;375(9711):283-93. doi: 10.1016/S0140-6736(09)62191-7. Epub 2010 Jan 13.

PMID:
20079528
13.

Ticagrelor versus clopidogrel in patients with acute coronary syndromes.

Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA; PLATO Investigators, Freij A, Thorsén M.

N Engl J Med. 2009 Sep 10;361(11):1045-57. doi: 10.1056/NEJMoa0904327. Epub 2009 Aug 30.

14.

Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein.

Ridker PM, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Khurmi NS, Koenig W, Libby P, Lorenzatti AJ, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Trial Study Group.

Am J Cardiol. 2007 Dec 1;100(11):1659-64. Epub 2007 Oct 24.

15.

Effects of A1 adenosine receptor agonism using N6-cyclohexyl-2'-O-methyladenosine in patients with left ventricular dysfunction.

Bertolet BD, Anand IS, Bryg RJ, Mohanty PK, Chatterjee K, Cohn JN, Khurmi NS, Pepine CJ.

Circulation. 1996 Sep 15;94(6):1212-5.

16.

Angiotensin converting enzyme inhibition in chronic stable angina: effects on myocardial ischaemia and comparison with nifedipine.

Ikram H, Low CJ, Shirlaw TM, Foy SG, Crozier IG, Richards AM, Khurmi NS, Horsburgh RJ.

Br Heart J. 1994 Jan;71(1):30-3.

17.

Effect of benazepril on myocardial ischaemia in patients with chronic stable angina pectoris.

Tzivoni D, Gottlieb S, Khurmi NS, Medina A, Gavish A, Stern S.

Eur Heart J. 1992 Aug;13(8):1129-34.

PMID:
1505563
18.
19.

Oral nitroglycerin in angina pectoris--evaluation of effect by computerized exercise testing using two different doses.

Kohli RS, Khurmi NS, Kardash MM, Lahiri A, Raftery EB.

Cardiovasc Drugs Ther. 1988 Nov;2(4):523-8.

PMID:
3155316
20.

Supplemental Content

Loading ...
Support Center